glp-1 medications approved for weight loss Options Market Overview: GLP-1 Agonists and
Description
Gastroenterology 143 , 913.e7916.e7 (2012)

doi:10.1152/ajpendo.00565.2012 11

(2012) Na(+)-D-glucose cotransporter SGLT1 is pivotal for intestinal glucose absorption and glucose-dependent incretin secretion
:max_bytes(150000):strip_icc()/VWH-MiraNorian-WeightLossDrugUpdate-4000x2700-c813fa5051604eec9c136047fb44d23a.png)
The available evidence suggests that older adults derive similar clinical benefits as younger adults with comparable weight loss and an equivalent associated impact on obesity-related complications, with likely improved adherence to treatment regimes
